Anna Shutkevich is a Production Development Group Lead with expertise in the clinical development of radiopharmaceuticals, currently overseeing preclinical and clinical projects at the State Atomic Energy Corporation "Rosatom." With over 18 years of experience in global clinical research across various therapeutic areas, Anna has successfully managed cross-border trials and integrated AI/ML into clinical studies. Previously, Anna held positions at Roche and Pfizer, contributing to rare disease studies and compliance initiatives. Anna’s educational background includes multiple master's degrees in Machine Learning and Data Science in Medicine, along with a solid foundation in Genetics, Microbiology, and Biology.
This person is not in the org chart
This person is not in any teams
This person is not in any offices